Baseline demographic and clinical characteristics of psoriatic arthritis (PsA) case and control populations.
| Characteristic | PsA, n = 48 | Controls, n = 42 | p |
|---|---|---|---|
| Age, yrs, ± SD | 50.96 ± 9.86 | 54.29 ± 11.49 | 0.143 |
| Male sex (%) | 24 (50.0) | 18 (42.9) | 0.531 |
| Impaired fasting glucose (%) | 14 (29.2) | 16 (38.1) | 0.382 |
| Hypercholesterolemia (%) | 26 (54.2) | 16 (38.1) | 0.144 |
| Hypertriglyceridemia (%) | 16 (33.3) | 12 (28.6) | 0.655 |
| Hypertransaminasemia (%) | 8 (16.7) | 14 (33.3) | 0.087 |
| Hypertension (%) | 14 (29.2) | 17 (40.5) | 0.276 |
| Smoking habit (%) | 10 (20.8) | 10 (23.8) | 0.802 |
| MetS (%) | 18 (37.5) | 14 (33.3) | 0.826 |
| ESR | 24.13 ± 14.17 | 10.86 ± 3.26 | < 0.001 |
| CRP | 3.29 ± 4.70 | 0.98 ± 0.60 | 0.002 |
| Hepatic steatosis (%) | |||
| Mild | 30 (62.5) | 20 (47.6) | |
| Moderate | 14 (29.2) | 18 (42.9) | 0.348* |
| Severe | 4 (8.3) | 4 (9.5) |
↵* p for trend. MetS: metabolic syndrome; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.